When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CYTR - Arimoclomol application in U.S. fails to lift CytoRx
CytRx Corporation
Thinly traded nano cap CytRx (OTCQB:CYTR-1.3%) is down out the gate this morning on the heels of its announcement that Orphazyme A/S has completed its rolling U.S. marketing application seeking approval of arimoclomol for the treatment of Niemann-Pick disease type-C, a rare inherited disorder characterized by the body's inability to metabolize cholesterol and other lipids leading to nerve and organ damage.
More news on: CytRx Corporation, Healthcare stocks news, Stocks on the move,